Goldman Sachs’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-563,003
| Closed | -$2.25M | – | 4654 |
|
|
2019
Q4 | $2.25M | Buy |
563,003
+353,846
| +169% | +$1.42M | ﹤0.01% | 2873 |
|
|
2019
Q3 | $1.03M | Buy |
209,157
+25,845
| +14% | +$127K | ﹤0.01% | 3239 |
|
|
2019
Q2 | $1.12M | Sell |
183,312
-12,849
| -7% | -$78.2K | ﹤0.01% | 3127 |
|
|
2019
Q1 | $1.14M | Buy |
196,161
+21,496
| +12% | +$125K | ﹤0.01% | 3202 |
|
|
2018
Q4 | $2.35M | Sell |
174,665
-48,308
| -22% | -$650K | ﹤0.01% | 2727 |
|
|
2018
Q3 | $4.33M | Sell |
222,973
-35,347
| -14% | -$686K | ﹤0.01% | 2510 |
|
|
2018
Q2 | $6.6M | Sell |
258,320
-181,287
| -41% | -$4.63M | ﹤0.01% | 2262 |
|
|
2018
Q1 | $8.86M | Buy |
439,607
+233,630
| +113% | +$4.71M | ﹤0.01% | 1992 |
|
|
2017
Q4 | $4.13M | Buy |
205,977
+10,573
| +5% | +$212K | ﹤0.01% | 2422 |
|
|
2017
Q3 | $4.05M | Buy |
195,404
+61,536
| +46% | +$1.27M | ﹤0.01% | 2488 |
|
|
2017
Q2 | $1.98M | Buy |
133,868
+18,348
| +16% | +$272K | ﹤0.01% | 2814 |
|
|
2017
Q1 | $1.84M | Sell |
115,520
-28,494
| -20% | -$454K | ﹤0.01% | 2789 |
|
|
2016
Q4 | $1.82M | Buy |
144,014
+78,871
| +121% | +$994K | ﹤0.01% | 2772 |
|
|
2016
Q3 | $1.83M | Buy |
65,143
+26,010
| +66% | +$729K | ﹤0.01% | 2759 |
|
|
2016
Q2 | $1.37M | Sell |
39,133
-20,148
| -34% | -$705K | ﹤0.01% | 2801 |
|
|
2016
Q1 | $1.62M | Buy |
59,281
+21,858
| +58% | +$599K | ﹤0.01% | 2630 |
|
|
2015
Q4 | $1.28M | Sell |
37,423
-6,199
| -14% | -$212K | ﹤0.01% | 2768 |
|
|
2015
Q3 | $1.25M | Buy |
43,622
+41,004
| +1,566% | +$1.18M | ﹤0.01% | 2787 |
|
|
2015
Q2 | $117K | Sell |
2,618
-11,571
| -82% | -$517K | ﹤0.01% | 4255 |
|
|
2015
Q1 | $491K | Sell |
14,189
-14,128
| -50% | -$489K | ﹤0.01% | 3325 |
|
|
2014
Q4 | $775K | Buy |
+28,317
| New | +$775K | ﹤0.01% | 3099 |
|